homocysteine has been researched along with Vascular Diseases in 257 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (4.28) | 18.7374 |
| 1990's | 73 (28.40) | 18.2507 |
| 2000's | 127 (49.42) | 29.6817 |
| 2010's | 40 (15.56) | 24.3611 |
| 2020's | 6 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Matsha, TE; Raghubeer, S | 1 |
| Das, K; Das, P; Dash, BP; Dehury, S; Jit, BP; Maske, MM; Meher, S; Mohanty, PK; Patel, S | 1 |
| Ali, MM; Bianco, FM; Cristoforo, GP; Frederick, P; Gangemi, A; Haloul, M; Hassan, C; Mahmoud, AM; Masrur, M; Mirza, MI; Naquiallah, D; Phillips, SA; Qureshi, M; Vinjamuri, SJ | 1 |
| Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S | 1 |
| Eyob, W; George, AK; Homme, RP; Sandhu, H; Singh, M; Stanisic, D; Tyagi, SC | 1 |
| Du, LP; Han, WL; Li, WM; Liang, DA; Lu, D; Wen, ZG | 1 |
| Gao, H; Hao, B; Premaratne, S; Su, X; Sun, L; Wang, S; Xu, H; Yang, T; Yao, J; Zhang, J; Zhang, W | 1 |
| Katsiki, N; Mikhailidis, DP; Perez-Martinez, P | 1 |
| Chen, AF; Chen, RF; Leng, YP; Li, XG; Li, XH; Li, YP; Ma, YS; Qiu, CF; Zeng, PY; Zhang, Z | 1 |
| Chen, CW; Hsieh, RH; Owaga, E; Tsai, IJ; Tsai, SY; Wang, PY | 1 |
| George, AK; Homme, RP; Laha, A; Majumder, A; Singh, M; Tyagi, SC | 1 |
| Andrews, RD; de Leon, MJ; Ganzer, C; Isaacson, RS; Matthews, DC; Mosconi, L; Osorio, RS; Quinn, C; Sterling, J; Vallabhajosula, S; Walters, MJ | 1 |
| Christians, U; Hildreth, KL; Keller, AC; Klawitter, J; Kohrt, WM; Moreau, KL; Putnam, K; Reusch, JEB | 1 |
| Abali, R; Alpsoy, S; Aydemir, B; Bastu, E; Celik, C; Guzel, EC; Yeh, J | 1 |
| Gard, PR; Nilforooshan, R; Richardson, C; Tabet, N; Weaving, G | 1 |
| Cronje, FJ; Davis, W; Erasmus, RT; Fisher, LR; Geiger, D; Hassan, MS; Kotze, MJ; Matsha, T; van der Merwe, L; van Rensburg, SJ; Whati, L | 1 |
| Amin, MA; Pushpakumar, SB; Sen, U; Tyagi, SC | 1 |
| Gupta, ED; Liew, SC | 1 |
| Bradshaw, B; Buettner, P; Golledge, J; Quigley, F; Smith, RK; Tosenovsky, P; Velu, R | 1 |
| Chen, CS; Hsiao, SM; Huang, MF; Hwang, SJ; Kuo, MC; Liu, TL; Tsai, JC; Yang, YH; Yeh, YC | 1 |
| Chae, H; Kim, H; Kim, M; Kim, Y; Lee, GD; Lee, JM; Lee, SY; Oh, YS; Park, J | 1 |
| Cetın, N; Karabel, D; Sav, NM; Yildirim, A; Yıldız, B | 1 |
| Bruce, I; Chin, AV; Coakley, D; Coen, R; Cunningham, CJ; Hamilton, F; Lawlor, BA; Molloy, A; O'Connell, H; Robinson, DJ; Scott, J; Walsh, B | 1 |
| Couper, JJ; Peña, AS | 1 |
| Gustafson, L; Hultberg, B; Nilsson, K | 11 |
| Bañes, I; Fridman, O; Gariglio, L; Junco, MN; Morales, A; Porcile, R; Potenzoni, MA; Vanasco, V | 1 |
| Hamed, SA | 1 |
| Bonadei, I; Dei Cas, L; Fiorina, C; Frattini, S; Raddino, R; Vizzardi, E; Zanini, G | 1 |
| Jakubowski, H | 3 |
| Acuto, S; Bono, A; Campisi, G; Guglielmini, E; Scazzone, C | 1 |
| De Tommaso, G; Iuliano, M; Ragone, R | 1 |
| Gustafson, L; Hultberg, B; Nilsson, K; Nornholm, M | 1 |
| Caccamo, D; Condello, S; Curro', M; Ferlazzo, N; Ientile, R; Pisani, F | 1 |
| Devlin, AM; Green, TJ; Innis, SM; McMahon, JA; Skeaff, CM; Venn, BJ; Williams, SM | 1 |
| Abdulle, AM; Gariballa, S; Moussa, N; Pathan, JY | 1 |
| Alpert, DR; Cooke, JP; Crow, MK; Devereux, RB; Lockshin, MD; Perna, M; Roman, MJ; Salmon, JE; Sammaritano, L | 1 |
| Böhmer, AE; Brum, LM; Hansel, G; Portela, LV; Souza, DG; Souza, DO | 1 |
| Bates, CJ; Hamer, M; Mansoor, MA; Mishra, GD; Pentieva, KD | 1 |
| Qiu, LH; Xie, XJ; Zhang, BQ | 1 |
| Dulin, E; García-Barreno, P; Guisasola, MC | 1 |
| Dionisio, N; Jardín, I; Rosado, JA; Salido, GM | 1 |
| Chang, PY; Chen, YJ; Lu, SC | 1 |
| Beard, RS; Bearden, SE | 1 |
| Bennett, D; Clarke, R; Halsey, J; Lewington, S | 1 |
| Beran-Praher, M; Fuchs, D; Haller, H; Leblhuber, F; Schroecksnadel, K; Steiner, K | 1 |
| Bian, L; Chen, X; Jiang, Y; Long, L; Wang, Q; Xu, Y; Yan, J; Yang, L; Zhang, L; Zhu, C | 1 |
| Ali, A; Bhargava, S; Parakh, R; Saxena, R; Srivastava, LM | 1 |
| Atkinson, W; Chambers, ST; Elmslie, JL; Frampton, CM; George, PM; Lever, M; Molyneux, SL; Richards, AM; Slow, S; Troughton, RW | 1 |
| Hamada, A; Mori, H; Mori, M; Taguchi, T; Yamori, Y | 1 |
| Bleich, S; Frieling, H; Haschemi-Nassab, M; Hillemacher, T; Kornhuber, J; Leitmeier, V; Rhein, M | 1 |
| Ali, A; Bhargava, S; Das, S; Kankra, M; Manocha, A; Srivastava, LM | 1 |
| Bacchi-Reggiani, L; Branzi, A; Carigi, S; Grigioni, F; Leone, O; Magelli, C; Magnai, G; Magnani, G; Poci, MG; Potena, L; Sassi, S; Sorbello, S | 1 |
| Fowler, PB | 1 |
| Shete, MM; Yeolekar, ME | 1 |
| Afman, LA; Blom, HJ; Boers, GH; den Heijer, M; Kluijtmans, LA; Lievers, KJ; Trijbels, FJ; Verhoef, P | 1 |
| Robinson, K | 1 |
| Wilcken, DE | 2 |
| Lain, KY; Lykins, DL; Majors, AK; Powers, RW; Roberts, JM; Sims, CJ | 1 |
| Agosti, C; Borroni, B; Di Luca, M; Padovani, A; Panzali, AF | 1 |
| Blom, HJ; Boers, GH; Den Heijer, M; Heil, SG; Kluijtmans, LA; Lievers, KJ; Trijbels, FJ; Verhoef, P | 1 |
| Demuth, K; Germain, DP | 1 |
| Landray, MJ; Townend, JN; Wheeler, DC | 1 |
| Kaplan, ED | 1 |
| Chiarello, PG; Vannucchi, H; Vannucchi, MT | 1 |
| Favier, A; Galan, P; Guilland, JC; Hercberg, S; Potier de Courcy, G | 1 |
| Seshadri, S; Wolf, PA | 1 |
| Buysschaert, M; Hermans, MP | 1 |
| Födinger, M; Konner, P; Müllner, M; Pleiner, J; Röhrer, C; Skoupy, S; Sunder-Plassmann, G; Vychytil, A; Wolzt, M | 1 |
| Carmel, R; Green, R; Rosenblatt, DS; Watkins, D | 1 |
| Frick, B; Fuchs, D; Leblhuber, F; Schroecksnadel, K; Winkler, C; Wirleitner, B | 1 |
| Stanger, O; Weger, M | 1 |
| Heydrick, SJ; Keaney, JF; Keller, C; Loscalzo, J; Postea, O; Weiss, N | 1 |
| Ahn, C; Aronow, WS; Storey, SG; Suryadevara, V | 1 |
| Acharya, N; Jacobsen, DW; Messerli, AW; Pearce, GL; Pohl, MA; Robinson, K; Seshadri, N; Sprecher, DL | 1 |
| Falcinelli, F; Floridi, A; Gresele, P; Imperiali, P; Migliacci, R; Nenci, GG | 1 |
| Kreuzer, J; Tiefenbacher, CP | 1 |
| Allen, R; Anand, K; Boden-Albala, B; Lee, HS; Paik, MC; Sacco, RL; Stabler, S | 1 |
| Eikelboom, JW; Hankey, GJ; Ho, WK; van Bockxmeer, FM | 1 |
| Chambers, ST; Dellow, WJ; George, PM; Lever, M; Scott, RS | 1 |
| Chai, H; Chen, C; Lin, PH; Lumsden, AB; Ramaswami, G; Yao, Q | 1 |
| Ebbesen, LS | 1 |
| Giusti, B; Lapini, I; Lenti, M; Marcucci, R; Pepe, G; Sestini, I; Yacoub, M | 1 |
| Stanger, O; Stühlinger, MC | 1 |
| Abbate, R; Gori, AM; Marcucci, R | 1 |
| Cetinalp, P; Kuskay, S; Maral, H; Ozdemir, G; Ozden, M; Tarkun, I | 1 |
| Avila, MA; Berasain, C; Corrales, FJ; García-Trevijano, ER; Mato, JM; Prieto, J | 1 |
| Bauer, DC; Jamal, SA; Leiter, RE | 1 |
| McDowell, IF; Moat, SJ | 1 |
| Moore, JL | 1 |
| Branzi, A; Carigi, S; Coccolo, F; Grigioni, F; Kessels, K; Koessels, K; Magelli, C; Magnani, G; Marrozzini, C; Marzocchi, A; Musuraca, AC; Ortolani, P; Potena, L; Russo, A; Sassi, S | 1 |
| Chang, KL; Huang, LW; Liu, HW; Pai, LS; Su, SJ | 1 |
| Becker, A; Huijberts, MS; Stehouwer, CD | 1 |
| Barbato, JC; Catanescu, O; Dibello, PM; Jacobsen, DW | 1 |
| Brini, M; Depunzio, I; Ferrante, F; Ghirarduzzi, A; Iorio, A; Mourvaki, E | 1 |
| Langhorne, P; Lowe, GD; MacDonald, JB; MacFarlane, PW; MacIntosh, G; McMahon, AD; O'Reilly, DS; Rumley, A; Spilg, EG; Stott, DJ; Tait, RC; Westendorp, RG | 1 |
| Loscalzo, J | 2 |
| Blom, HJ; Castro, R; Jakobs, C; Rivera, I; Tavares de Almeida, I | 1 |
| Kalmijn, S; Mali, WP; van der Graaf, Y; van Raamt, AF; van Zandvoort, MJ | 1 |
| Selhub, J | 1 |
| Ziegler, R | 1 |
| Liakishev, AA | 1 |
| Belva-Besnet, H; Casetta, B; Ducros, V; Favier, A | 1 |
| Bauer, JA; Groner, JA; Joshi, M | 1 |
| Bianchin, M; Chiappelli, M; Forti, P; Licastro, F; Maioli, F; Montesi, F; Patterson, C; Ravaglia, G | 1 |
| Del Zotto, E; Padovani, A; Pezzini, A | 1 |
| Akoglu, B; Caspary, WF; Faust, D; Kindl, P; Trojan, J; Weber, N | 1 |
| Cai, B; Gong, D; Jiao, J; Liu, Y; Lu, Y; Pan, Z; Qian, H; Yang, B; Zhang, Y | 1 |
| Kurihara, H | 1 |
| Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
| Glushchenko, AV; Jacobsen, DW | 1 |
| Gaziano, JM; Goldfarb, DS; Guarino, PD; Hartigan, P; Jamison, RL; Kaufman, JS; Warren, SR | 1 |
| Baigent, C; Clarke, R | 1 |
| Nanayakkara, PW; Stehouwer, CD; van Guldener, C | 1 |
| McCully, KS | 1 |
| Koury, MJ; Wagner, C | 2 |
| Chowienczyk, P; Forrester, T; Iveson, E; Kalra, L; Rambaran, C; Ritter, J; Shah, A; Sherwood, R | 1 |
| Lai, L; Liu, F; Liu, G; Wang, B; Wang, R; Yin, H; Yu, S; Zhang, J | 1 |
| Armitage, J; Clarke, R; Collins, R; Lewington, S | 1 |
| Shalash, OA; Soliman, EZ | 1 |
| O'Brien, JT; Teper, E | 1 |
| Dudman, NP; Kuchel, PW; Lundberg, P; Wilcken, DE | 1 |
| Bachmann, J; Graefe, U; Langer, K; Raidt, H; Riezler, R; Tepel, M; Zidek, W | 1 |
| Berwanger, CS; Jeremy, JY; Stansby, G | 1 |
| Fortin, LJ; Genest, J | 1 |
| Blom, HJ; Boers, GJ; den Heijer, M; Frosst, P; Goyette, P; Kluijtmans, LA; Matthews, RG; Milos, R; Sheppard, CA; van den Heuvel, LP | 1 |
| Blom, HJ; Boers, GH; Engbersen, AM; Franken, DG; Stevens, EM; Trijbels, FJ | 1 |
| Barlatier, A; Bodard, H; Charpiot, P; Faye, MM; Friggi, A; Ghiringhelli, O; Guillou, J; Latrille, V; Piquet, P; Rolland, PH | 1 |
| Blom, HJ; Boers, GH; Franken, DG; Trijbels, JM | 1 |
| Boers, GH | 3 |
| Rees, MM; Rodgers, GM | 1 |
| Bostom, AG; Catalfamo, J; Eaton, CB; McQuade, W; Selhub, J; Yanek, L | 1 |
| Fitzgerald, LA; Fryer, RH; Gubler, DB; Rodgers, GM; Wilson, BD | 1 |
| Bhopatkar, MY; Faraci, FM; Heistad, DD; Lentz, SR; Malinow, MR; Piegors, DJ; Sobey, CG | 1 |
| Allen, RH; Lindenbaum, J; Stabler, SP | 1 |
| Kang, SS; Wong, PW | 1 |
| Andersson, A; Brattström, L; Fäldt, R; Gustafson, L; Hultberg, B; Israelsson, B; Lindgren, A; Nilsson, K | 1 |
| Evans, AE; Gey, KF; Harmon, DL; McCrum, EE; McMaster, D; Whitehead, AS; Woodside, JV; Yarnell, JW; Young, IS | 1 |
| Deloughery, TG; Evans, A; Henner, WD; McWilliams, J; Press, RD; Sadeghi, A; Taylor, LM | 1 |
| Baumgartner, RN; Garry, PJ; Koehler, KM; Pareo-Tubbeh, SL; Romero, LJ | 1 |
| Cole, DE; Evrovski, J; Miner, SE | 1 |
| Andria, G; Bellet, H; Boers, GH; Brattström, LE; Daly, LE; de Valk, HW; Garcon, D; Graham, IM; Higgins, I; Israelsson, B; McMaster, D; Meleady, R; Palma-Reis, RJ; Parrot-Rouland, FM; Refsum, HM; Robinson, K; Rubba, P; Sales Lúis, AC; Sheahan, RG; Tan, KS; Ueland, PM; Uiterwaal, CS; Verhoef, P; Wautrecht, JC; Witteman, J | 1 |
| Bellamy, MF; McDowell, IF | 1 |
| Chango, A; Nicolas, JP | 1 |
| Catalano, PM; Malinow, MR; Rajkovic, A | 1 |
| Lentz, SR | 1 |
| Dennis, VW; Nurko, S; Robinson, K | 1 |
| Berent, H; Gurba, H; Nowakowski, P; Wocial, B | 1 |
| Bates, CJ; Cole, TJ; Finch, S; Mansoor, MA; Prentice, A; van der Pols, J | 1 |
| Celermajer, DS; Chan, LT; Cheung, AS; Chook, P; Lolin, YI; Metreweli, C; Sanderson, JE; Sun, YY; Woo, KS | 2 |
| Bottiglieri, T; Lowenthal, D; Parnetti, L | 1 |
| Bax, J; Bulterijs, EJ; de Jong, SC; Mackaay, AJ; Rauwerda, JA; Stehouwer, CD; van den Berg, M; Visser, FC | 1 |
| Arheart, K; Boers, G; Brattström, L; Daly, L; Graham, I; Meleady, R; Palma-Reis, R; Refsum, H; Robinson, K; Rubba, P; Ueland, P; Witteman, J | 1 |
| Ferguson, E; Joseph, J; Kalyanaraman, B; Parthasarathy, S | 1 |
| Adão, M; Azinheira, J; Bordalo-Sá, AL; Correia, JM; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L; Tavares, J | 1 |
| Goebeler, M; Harms, E; Koch, HG; Marquardt, T; Roth, J | 1 |
| Boers, G | 1 |
| O'Sullivan, J; Townend, J; Wilde, JT | 1 |
| Green, R | 1 |
| Bernardini, S; Cortese, C; Federici, G; Gnasso, A; Massoud, R; Motti, C; Pastore, A; Rampa, P | 1 |
| Caldwell, S | 1 |
| Eskes, TK | 1 |
| Clarke, R; Jobst, KA; Refsum, H; Smith, AD; Sutton, L; Ueland, PM | 1 |
| Ankri, A; Aupetit, J; Bonnefont, JP; Chadefaux-Vekemans, B; Couty, MC; Kamoun, P; Kara, A; Montalescot, G; Rochette, C; Thuillier, L | 1 |
| Moustapha, A; Robinson, K | 1 |
| Ecker-Schlipf, B | 1 |
| Bailey, LB; Gregory, JF | 1 |
| Mohan, IV; Stansby, G | 1 |
| Stoney, CM | 1 |
| Fowler, B; Kuhn, W; Müller, T; Werne, B | 1 |
| Brown, MJ; Hockly, E | 1 |
| Boers, GH; Daly, LE; Graham, IM; Meleady, R; Robinson, K; Verhoef, P | 1 |
| Bellamy, MF; Brownlee, M; Lewis, MJ; McDowell, IF; Newcombe, RG; Ramsey, MW | 1 |
| Cole, DE; Langman, LJ | 1 |
| Lyngbak, M; Moller, J; Rasmussen, K | 1 |
| Donker, AJ; Lambert, J; Rauwerda, JA; Stehouwer, CD; Steyn, M; van den Berg, M | 1 |
| Engman, M | 1 |
| Pallardó, FV; Viña, JR | 1 |
| Blann, AD; Boisseau, M; Conri, C; Constans, J; Guérin, V; Parrot, F; Renard, M; Resplandy, F; Seigneur, M | 1 |
| Wang, X | 1 |
| Chisholm, A; Duncan, A; Mann, JI; Riddell, LJ | 1 |
| Gejyo, F; Kimura, H; Miyazaki, R; Suzuki, S | 1 |
| Dudman, NP; Fu, W; Perry, MA; Wang, XL; Young, K | 1 |
| Cipriano, C; Conri, C; Constans, J; Parrot, F; Skopinski, S | 1 |
| Fridman, O | 1 |
| Arends, GE; Blom, HJ; Eskes, TK; Heil, SG; Nelen, WL; van der Molen, EF; van der Put, NJ | 1 |
| Berrettini, M; Burlina, A; Cella, G; Girolami, A; Motta, G; Sbarai, A; Strauss, W | 1 |
| Perry, DJ | 1 |
| Thambyrajah, J; Townend, JN | 1 |
| Duarte, N; Trudinger, BJ; Wang, J; Wang, XL; Wilcken, DE | 1 |
| Bar-Meir, E; George, J; Shoenfeld, Y | 1 |
| Morrow, LE | 1 |
| Boers, GH; Naughten, ER; Wilcken, B; Wilcken, DE; Yap, S | 1 |
| Diaz-Arrastia, R | 1 |
| Kruger, WD | 1 |
| Bonham, JR; Moat, SJ; Powers, HJ | 1 |
| Christen, WG; Ridker, PM | 1 |
| Artner-Dworzak, E; Fuchs, D; Leblhuber, F; Vrecko, K; Walli, J; Widner, B | 1 |
| Batista, M; Camera, MI; Janson, J; Kordich, LC; Murúa, AL; Quintana, I | 1 |
| Arakawa, K; Coetzee, GA; Lee, HP; Ong, CN; Saw, SM; Yu, MC; Yuan, JM | 1 |
| Allen, RH; Baumgartner, RN; Garry, PJ; Koehler, KM; Rimm, EB; Stabler, SP | 1 |
| Bersier, LF; Boulat, O; Descombes, E; Fellay, G | 1 |
| Hajjar, KA | 1 |
| El-Khairy, L; Graham, IM; Refsum, H; Ueland, PM; Vollset, SE | 1 |
| DiBello, PM; Jacobsen, DW; Poddar, R; Robinson, K; Sivasubramanian, N | 1 |
| Azinheira, J; Cândido, A; Correia, JM; Correia, MJ; Duarte, R; Gomes, E; Luís, AS; Pina, JE; Reis, HP; Reis, RP | 1 |
| Armani, U; Cerone, R; Lorini, R; Minniti, G; Piana, A | 1 |
| Miller, JW | 1 |
| Nakanishi, T; Takamitsu, Y | 1 |
| Herrmann, W | 1 |
| Artner-Dworzak, E; Fuchs, D; Jaeger, M; Leblhuber, F; Widner, B; Wirleitner, B | 1 |
| Konetschny, R; Renner, W; Stanger, O; Weger, M | 1 |
| Panini, R; Salvioli, G; Scarpetta, G; Ventura, P; Verlato, C | 1 |
| Aigelsdorfer, J; Furtmueller, B; Haltmayer, M; Luft, C; Mueller, T; Poelz, W | 1 |
| Ragone, R | 1 |
| Enzinger, C; Fuchs, D; Laich, A; Widner, B; Wirleitner, B | 1 |
| Bartłomiejczyk, J; Foroncewicz, B; Juskowa, J; Mucha, K; Paczek, L; Plomiński, YP; Rowinski, W; Szmidt, J | 1 |
| Green, R; Jagust, WJ; Miller, JW; Mungas, DM; Reed, BR | 1 |
| Haltmayer, M; Mueller, T; Poelz, W | 1 |
| Asnani, S; Desouza, C; Fonseca, V; Homan, J; McNamara, DB; Murthy, SN | 1 |
| Cook, JW; Malinow, MR; Orloff, SL; Yin, Q | 1 |
| Bell, IR; Cole, JO; Edman, JS; Kayne, HL; Marby, DW; Morrow, FD; Selhub, J | 1 |
| Kang, SS; Malinow, MR; Wong, PW | 1 |
| Andersson, A; Brattström, L; Hamfelt, A; Hultberg, B; Isaksson, A; Israelsson, B | 1 |
| Brattström, L; Hultberg, B; Israelsson, B | 2 |
| Ambrosi, P; Barlatier, A; Bodard, H; Calaf, R; Charpiot, P; Friggi, A; Garçon, D; Habib, M; Joachim, J; Perrin, S | 1 |
| Cahalane, S; Clarke, R; Daly, L; Fowler, B; Graham, I; Naughten, E; Robinson, K | 1 |
| Hladovec, J | 1 |
| Coccheri, S | 1 |
| Skovby, F | 1 |
| Refsum, H; Ueland, PM | 1 |
| Blom, HJ; Boers, GH; Tangerman, A; Trijbels, JM; van den Elzen, JP; van Roessel, JJ | 1 |
| Brattström, L; Hultberg, B; Israelsson, B; Lindgärde, F | 1 |
| Dudman, NP; Robertson, MR; Tyrrell, PA; Wilcken, DE | 1 |
| Mudd, SH | 1 |
93 review(s) available for homocysteine and Vascular Diseases
| Article | Year |
|---|---|
Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks.
Topics: Carbon Cycle; Cardiovascular Diseases; Diabetes Mellitus; Epigenesis, Genetic; Female; Folic Acid; Heart Disease Risk Factors; Homocysteine; Humans; Inflammation; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Vascular Diseases; Vitamin B 12 | 2021 |
Regulation of the parental gene GRM4 by circGrm4 RNA transcript and glutamate-mediated neurovascular toxicity in eyes.
Topics: Animals; Cystathionine beta-Synthase; Endothelial Cells; Epigenesis, Genetic; Eye; Eye Diseases; Glutamic Acid; Homocysteine; Humans; Hyperhomocysteinemia; MicroRNAs; Receptors, Metabotropic Glutamate; RNA, Circular; Vascular Diseases | 2021 |
Homocysteine and Non-Cardiac Vascular Disease.
Topics: Animals; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Artery Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Peripheral Arterial Disease; Vascular Diseases | 2017 |
Remote ischemic conditioning as a cytoprotective strategy in vasculopathies during hyperhomocysteinemia: An emerging research perspective.
Topics: Animals; Cytokines; Endoplasmic Reticulum Stress; Homocysteine; Homocysteine S-Methyltransferase; Humans; Hyperhomocysteinemia; Inflammation; Ischemia; Mesenchymal Stem Cells; Mice; Oxidative Stress; Reactive Oxygen Species; Reperfusion; Vascular Diseases | 2019 |
Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator.
Topics: Adenosine Triphosphate; Anaerobiosis; Animals; Homocysteine; Humans; Hydrogen Sulfide; Kidney; Kidney Diseases; Mice; Rats; Vascular Diseases | 2014 |
Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases.
Topics: Diabetes Mellitus; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Infertility; Mental Disorders; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasms; Nervous System Diseases; Polymorphism, Genetic; Psoriasis; Vascular Diseases; Vitamin B 12 | 2015 |
Plasma homocysteine and vascular disease in elderly patients with mental illness.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Dementia; Homocysteine; Humans; Mental Disorders; Risk Factors; Vascular Diseases | 2008 |
The vascular risk associations with migraine: relation to migraine susceptibility and progression.
Topics: Blood Pressure; Body Mass Index; Body Weight; C-Reactive Protein; Comorbidity; Disease Susceptibility; Homocysteine; Humans; Inflammation; Interleukins; Migraine Disorders; Risk; Risk Factors; Stroke; Tumor Necrosis Factor-alpha; Vascular Diseases | 2009 |
Homocysteine and heart failure: an overview.
Topics: Animals; Clinical Trials as Topic; Heart Failure; Homocysteine; Humans; Hyperhomocysteinemia; Vascular Diseases; Vitamin B 12 Deficiency | 2009 |
The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cystathionine beta-Synthase; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Methionine-tRNA Ligase; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Thrombosis; Vascular Diseases | 2008 |
Homocysteine, vitamin determinants and neurological diseases.
Topics: Avitaminosis; Homocysteine; Humans; Hyperhomocysteinemia; Nervous System Diseases; Polymorphism, Genetic; Vascular Diseases; Vitamin B Complex | 2010 |
Homocysteine, intracellular signaling and thrombotic disorders.
Topics: Animals; Blood Platelets; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Signal Transduction; Thrombosis; Vascular Diseases | 2010 |
Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.
Topics: Animals; Disease Models, Animal; Homocysteine; Homocystinuria; Humans; Hydrogen Sulfide; Mice; Vascular Diseases | 2011 |
Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
Topics: Cause of Death; Clinical Trials as Topic; Dietary Supplements; Down-Regulation; Folic Acid; Homocysteine; Humans; Neoplasms; Vascular Diseases; Vitamin B Complex | 2011 |
Quality control in tRNA charging -- editing of homocysteine.
Topics: Amino Acyl-tRNA Synthetases; Animals; Brain Diseases; Catalytic Domain; Escherichia coli; Homocysteine; Humans; Hydrolysis; Hyperhomocysteinemia; Substrate Specificity; Transfer RNA Aminoacylation; Vascular Diseases | 2011 |
Homocysteine and hypertension.
Topics: Age Factors; Diabetes Complications; Diabetes Mellitus; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Risk Factors; Vascular Diseases | 2002 |
Homocysteine, smoking and vascular disease.
Topics: Homocysteine; Humans; Smoking; Vascular Diseases | 2002 |
Association between homocyst(e)ine levels and risk of vascular events.
Topics: Adult; Aged; Avitaminosis; Child; Diet; Female; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Vascular Diseases | 2003 |
[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Topics: Animals; Arteriosclerosis; Biomarkers; Cystathionine beta-Synthase; Folic Acid Deficiency; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Nitric Oxide; Oxidative Stress; Oxidoreductases Acting on CH-NH Group Donors; Rats; Risk Factors; S-Adenosylmethionine; Signal Transduction; Thrombophilia; Vascular Diseases; Vasodilation; Vitamin B 6 Deficiency | 2003 |
[How to treat and manage hyperhomocysteinemia].
Topics: Diabetes Complications; Homocysteine; Humans; Hyperhomocysteinemia; Vascular Diseases | 2003 |
Update on cobalamin, folate, and homocysteine.
Topics: Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Metabolism, Inborn Errors; Polymorphism, Genetic; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 2003 |
Hyperhomocysteinemia and immune activation.
Topics: Cytokines; Dementia; Homocysteine; Humans; Hyperhomocysteinemia; Reactive Oxygen Species; Vascular Diseases | 2003 |
Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
Topics: Endothelium, Vascular; Folic Acid; Free Radicals; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Vascular Diseases | 2003 |
Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
Topics: Animals; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Vascular Diseases | 2003 |
Nitric oxide-mediated endothelial dysfunction--is there need to treat?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Clinical Trials as Topic; Endothelium, Vascular; Homocysteine; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide; Vascular Diseases | 2003 |
Clinical usefulness of plasma homocysteine in vascular disease.
Topics: Arteriosclerosis; Australia; Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Humans; Incidence; Male; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Vascular Diseases | 2004 |
Hyperhomocysteinemia, thrombosis and vascular biology.
Topics: Animals; Blood Coagulation; Blood Vessels; Cells, Cultured; Extracellular Matrix; Fibrinolysis; Folic Acid Deficiency; Gene Expression Regulation; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Myocytes, Smooth Muscle; Oligonucleotide Array Sequence Analysis; Platelet Activation; Rats; Risk; Thrombelastography; Thrombosis; Time Factors; Vascular Diseases | 2004 |
Role of hyperhomocysteinemia in aortic disease.
Topics: Aged; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Diseases; Collagen; Disease Progression; Extracellular Matrix; Female; Fibrillin-1; Fibrillins; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Marfan Syndrome; Microfilament Proteins; Middle Aged; Risk; Thrombosis; Vascular Diseases | 2004 |
Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Topics: Animals; Arginine; Arteriosclerosis; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Vascular Diseases | 2005 |
Influence of impaired liver methionine metabolism on the development of vascular disease and inflammation.
Topics: Animals; Homocysteine; Humans; Inflammation; Liver; Liver Diseases; Methionine; Vascular Diseases | 2005 |
Homocysteine and endothelial function in human studies.
Topics: Blood Flow Velocity; Endothelium, Vascular; Folic Acid; Hematinics; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Vascular Diseases; Vasodilation | 2005 |
The significance of folic acid for epilepsy patients.
Topics: Anticonvulsants; Epilepsy; Female; Folic Acid; History, 20th Century; Homocysteine; Humans; Male; Methionine; Models, Biological; Neural Tube Defects; Pregnancy; Vascular Diseases | 2005 |
Homocysteine and vascular disease in diabetes: a double hit?
Topics: Diabetes Complications; Homocysteine; Humans; Vascular Diseases | 2005 |
Molecular targeting by homocysteine: a mechanism for vascular pathogenesis.
Topics: Animals; Blood Proteins; Endothelial Cells; Homocysteine; Humans; Membrane Proteins; Vascular Diseases | 2005 |
Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.
Topics: Animals; DNA Methylation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Models, Biological; Vascular Diseases; Vitamin B Complex | 2006 |
The many facets of hyperhomocysteinemia: studies from the Framingham cohorts.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cardiovascular Diseases; Carotid Stenosis; Cohort Studies; Dementia; Diet; Female; Folic Acid; Fractures, Bone; Heart Failure; Homocysteine; Humans; Hyperhomocysteinemia; Male; Massachusetts; Middle Aged; Risk Factors; Stroke; Vascular Diseases; Vitamin B 12; Vitamin B 6 | 2006 |
Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents.
Topics: Adolescent; Adult; Arteries; Atherosclerosis; Cardiovascular Diseases; Child; Elasticity; Homocysteine; Humans; Inflammation; Pediatrics; Risk Factors; Tunica Intima; Vascular Diseases | 2006 |
Homocysteine and cerebral ischemia: pathogenic and therapeutical implications.
Topics: Brain Ischemia; Diet; Homocysteine; Humans; Life Style; Methylenetetrahydrofolate Reductase (NADPH2); Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vascular Diseases; Vitamins | 2007 |
[Homocysteine].
Topics: Homocysteine; Humans; Metabolic Syndrome; Vascular Diseases | 2006 |
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.
Topics: Arginine; Citrulline; Dietary Supplements; Hepatocytes; Homocysteine; Humans; Kidney Diseases; Liver Diseases; Nitric Oxide Synthase; Obesity; Risk Factors; Vascular Diseases | 2007 |
Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease.
Topics: Animals; Blood Proteins; Homocysteine; Humans; Membrane Proteins; Models, Biological; Vascular Diseases | 2007 |
The molecular basis of homocysteine thiolactone-mediated vascular disease.
Topics: Fibrinogen; Homocysteine; Humans; Immunity, Innate; Proteins; Vascular Diseases | 2007 |
Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.
Topics: Arginine; Homocysteine; Humans; Kidney Failure, Chronic; Vascular Diseases | 2007 |
Homocysteine, vitamins, and vascular disease prevention.
Topics: Aged; Atherosclerosis; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vascular Diseases; Vitamin B 12; Vitamin B 6 | 2007 |
S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine?
Topics: Homocysteine; Humans; S-Adenosylhomocysteine; Vascular Diseases | 2007 |
Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
Topics: Confidentiality; Cooperative Behavior; Homocysteine; Humans; Treatment Outcome; Vascular Diseases | 2007 |
Vascular factors and depression.
Topics: Autonomic Nervous System; Biomarkers; Cytokines; Depression; Endothelium, Vascular; Fatty Acids, Omega-3; Genetic Predisposition to Disease; Homocysteine; Humans; Hydrocortisone; Risk Factors; Vascular Diseases | 2008 |
Homocysteine and vascular disease.
Topics: Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Peripheral Vascular Diseases; Thrombophlebitis; Vascular Diseases | 1995 |
Measurement of homocyst(e)ine in the prediction of arteriosclerosis.
Topics: Arteriosclerosis; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Homocysteine; Homocystine; Humans; Male; Predictive Value of Tests; Risk Factors; Vascular Diseases | 1995 |
Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
Topics: Arteriosclerosis; Betaine; Coronary Disease; Folic Acid; Heterozygote; Homocysteine; Homocystinuria; Homozygote; Humans; Methionine; Pyridoxine; Risk Factors; Vascular Diseases | 1994 |
Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Blood Coagulation Factors; Blood Platelets; Child; Cystathionine beta-Synthase; Endothelium, Vascular; Fibrinolytic Agents; Folic Acid Deficiency; Homocysteine; Humans; Incidence; Male; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Penicillamine; Risk Factors; Thrombosis; Vascular Diseases; Vitamin B 12; Vitamin B 6 Deficiency; Vitamins | 1993 |
High prevalence of cobalamin deficiency in the elderly.
Topics: Aged; Hematologic Diseases; Homocysteine; Humans; Mental Disorders; Methylmalonic Acid; Nervous System Diseases; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 1996 |
Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
Topics: Amino Acid Metabolism, Inborn Errors; Cystathionine beta-Synthase; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Phenotype; Prevalence; Risk Factors; Vascular Diseases | 1996 |
Folate nutrition and older adults: challenges and opportunities.
Topics: Aged; Aged, 80 and over; Aging; Female; Folic Acid; Food, Fortified; Homocysteine; Homocystinuria; Humans; Male; Nutritional Status; Risk Factors; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 1997 |
Clinical chemistry and molecular biology of homocysteine metabolism: an update.
Topics: Female; Genotype; Homocysteine; Homocystinuria; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Neural Tube Defects; Oxidoreductases Acting on CH-NH Group Donors; Practice Guidelines as Topic; Renal Insufficiency; Vascular Diseases; Vitamin B Deficiency | 1997 |
Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
Topics: Arterial Occlusive Diseases; Homocysteine; Homozygote; Humans; Risk Factors; Thrombophlebitis; Vascular Diseases | 1997 |
Putative mechanisms for vascular damage by homocysteine.
Topics: Homocysteine; Homocystinuria; Humans; Vascular Diseases | 1997 |
Homocysteine and vascular dysfunction.
Topics: Animals; Arteriosclerosis; Disulfides; Endothelium, Vascular; Homocysteine; Humans; Thrombosis; Vascular Diseases | 1997 |
Hyperhomocysteinemia: detection, risk assessment, and treatment.
Topics: Animals; Homocysteine; Humans; Kidney Failure, Chronic; Methionine; Risk Factors; Vascular Diseases | 1997 |
[Homocysteine as a risk factor for vascular changes].
Topics: Cells, Cultured; Endothelium, Vascular; Homocysteine; Humans; Risk Factors; Vascular Diseases | 1997 |
Role of homocysteine in age-related vascular and non-vascular diseases.
Topics: Aged; Aging; Alcoholism; Central Nervous System; Cerebrovascular Disorders; Cognition; Coronary Disease; Depression; Estrogens; Female; Folic Acid Deficiency; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Peripheral Vascular Diseases; Renal Replacement Therapy; Vascular Diseases; Vitamin B 12 Deficiency | 1997 |
The redox status of aminothiols as a clue to homocysteine-induced vascular damage?
Topics: Arteriosclerosis; Endoplasmic Reticulum; Homocysteine; Humans; NF-kappa B; Oxidation-Reduction; Protein Folding; Sulfhydryl Compounds; Vascular Diseases | 1998 |
Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Homocysteine; Homocystinuria; Humans; Odds Ratio; Risk Factors; Smoking; Thrombosis; Vascular Diseases | 1998 |
Hyperhomocysteinaemia and vascular disease.
Topics: Arteries; Case-Control Studies; Controlled Clinical Trials as Topic; Disease Susceptibility; Homocysteine; Humans; Risk Factors; Thrombophlebitis; Vascular Diseases | 1998 |
Open or closed? A world of difference: a history of homocysteine research.
Topics: Animals; Female; Folic Acid; Homocysteine; Humans; Metabolism, Inborn Errors; Neural Tube Defects; Oxidoreductases Acting on CH-NH Group Donors; Pregnancy; Vascular Diseases | 1998 |
High plasma homocysteine: a risk factor for vascular disease in the elderly.
Topics: Aged; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vascular Diseases | 1998 |
[What role does homocysteine play in vascular diseases?].
Topics: Animals; Homocysteine; Humans; Vascular Diseases | 1999 |
Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement.
Topics: Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasms; Neural Tube Defects; Nutritional Requirements; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Vascular Diseases | 1999 |
Homocysteine.
Topics: Amino Acid Metabolism, Inborn Errors; Female; Homocysteine; Humans; Male; Neural Tube Defects; Vascular Diseases | 1999 |
Homocysteinemia: new information about an old risk factor for vascular disease.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Female; Homocysteine; Humans; Insurance, Life; Male; Metabolic Diseases; Middle Aged; Risk Factors; Vascular Diseases | 1998 |
[Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
Topics: Brain Ischemia; Homocysteine; Humans; Hyperhomocysteinemia; N-Methylaspartate; Nitric Oxide; Nitric Oxide Synthase; Receptors, N-Methyl-D-Aspartate; Risk Factors; Thrombosis; Vascular Diseases | 1999 |
Hyperhomocysteinaemia.
Topics: Animals; Dietary Supplements; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Pregnancy; Risk Factors; Thrombophilia; Thrombosis; Vascular Diseases; Vitamin B Complex | 1999 |
Homocysteine and atherothrombosis--mechanisms for injury.
Topics: Animals; Arteriosclerosis; Blood Platelets; Cell Division; Endothelium, Vascular; Homocysteine; Humans; Leukocytes; Lipoproteins, LDL; Muscle, Smooth, Vascular; Oxidation-Reduction; Thrombosis; Vascular Diseases | 2000 |
[Hyperhomocysteinemia--a risk factor or vascular disease?].
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vascular Diseases | 1999 |
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
Topics: Adolescent; Adult; Aged; Australia; Child; Child, Preschool; Cohort Studies; Cystine; Drug Resistance; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Infant; Ireland; Male; Methionine; Middle Aged; Netherlands; Pyridoxine; Risk; Risk Factors; Thrombophilia; Vascular Diseases; Vitamin B 12 | 2000 |
Homocysteine and neurologic disease.
Topics: Brain Diseases; Epilepsy; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Neurodegenerative Diseases; Pyridoxine; Vascular Diseases; Vitamin B 12 | 2000 |
Vitamins and homocysteine metabolism.
Topics: Folic Acid Deficiency; Homocysteine; Humans; Neural Tube Defects; Nutritional Status; Vascular Diseases; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency; Vitamins | 2000 |
Blood levels of homocysteine and atherosclerotic vascular disease.
Topics: Arteriosclerosis; Case-Control Studies; Cross-Sectional Studies; Homocysteine; Humans; Prospective Studies; Risk; Vascular Diseases | 2000 |
Homocysteine: a sulph'rous fire.
Topics: Animals; Arteriosclerosis; Female; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Inflammation; Male; Vascular Diseases | 2001 |
[From gene to disease; from homocysteine to hyperhomocysteinemia].
Topics: Cystathionine beta-Synthase; Folic Acid; Heterozygote; Homocysteine; Homocystinuria; Homozygote; Humans; Hyperhomocysteinemia; Methionine; Mutation; Risk Factors; Vascular Diseases | 2001 |
Does lowering plasma homocysteine reduce vascular disease risk?
Topics: Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Pyridoxine; Risk Factors; Vascular Diseases | 2001 |
Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure.
Topics: Animals; Arteriosclerosis; Chronic Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Renal Dialysis; Stress, Mechanical; Vascular Diseases | 2001 |
The importance of hyperhomocysteinemia as a risk factor for diseases: an overview.
Topics: Diet, Vegetarian; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Male; Methylation; Models, Biological; Models, Chemical; Pregnancy; Risk Factors; Vascular Diseases; Vitamin B 12 Deficiency | 2001 |
Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
Topics: Endothelium, Vascular; Free Radicals; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Models, Biological; Models, Chemical; Oxidative Stress; Vascular Diseases; Venous Thrombosis | 2001 |
Hyperhomocysteinemia, pteridines and oxidative stress.
Topics: Animals; Folic Acid; Homocysteine; Humans; Immunity; Oxidative Stress; Pteridines; Risk Factors; Vascular Diseases | 2002 |
Hormones and homocysteine.
Topics: Diabetic Angiopathies; Homocysteine; Hormones; Humans; Hyperhomocysteinemia; Hyperlipidemias; Methionine; Vascular Diseases | 2002 |
Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Arterial Occlusive Diseases; Homocysteine; Homocystine; Humans; Thromboembolism; Vascular Diseases | 1992 |
[Hyperhomocysteinemia--a new risk factor for vascular diseases?].
Topics: Homocysteine; Homocystinuria; Humans; Risk Factors; Vascular Diseases | 1992 |
Premature vascular disease in homocysteinaemia. Introduction.
Topics: Child; Homocysteine; Humans; Vascular Diseases | 1989 |
Plasma homocysteine and methionine tolerance in early-onset vascular disease.
Topics: Drug Tolerance; Homocysteine; Humans; Methionine; Risk Factors; Vascular Diseases | 1989 |
Inborn errors of metabolism causing homocysteinemia and related vascular involvement.
Topics: Homocysteine; Humans; Metabolism, Inborn Errors; Vascular Diseases | 1989 |
Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
Topics: Animals; Deficiency Diseases; Female; Homocysteine; Humans; Male; Methionine; Rats; Risk Factors; Sex Factors; Vascular Diseases | 1989 |
Homocysteine, folic acid, and the prevention of vascular disease.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Metabolism, Inborn Errors; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 1989 |
11 trial(s) available for homocysteine and Vascular Diseases
| Article | Year |
|---|---|
Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Aspartate Aminotransferases; Bilirubin; Blood Platelets; Female; Fetal Hemoglobin; Hemolysis; Homocysteine; Humans; L-Lactate Dehydrogenase; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Platelet Activation; Platelet Count; Polymorphism, Genetic; Vascular Diseases | 2019 |
Serum homocysteine is associated with the severity of primary chronic venous disease.
Topics: Adult; Aged; Chronic Disease; Female; Homocysteine; Humans; Male; Middle Aged; Severity of Illness Index; Vascular Diseases | 2016 |
Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
Topics: Aged; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Placebos; S-Adenosylhomocysteine; S-Adenosylmethionine; Vascular Diseases; Vitamin B 12; Vitamin B 6; Vitamins | 2010 |
Acute effect of amino acid peritoneal dialysis solution on vascular function.
Topics: Adult; Amino Acids; Blood Flow Velocity; Blood Pressure; Cross-Over Studies; Endothelium, Vascular; Forearm; Glucose; Homocysteine; Humans; Hyperemia; Kidney Failure, Chronic; Middle Aged; Nitroglycerin; Peritoneal Dialysis; Plethysmography; Solutions; Vascular Diseases | 2003 |
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study.
Topics: Adult; Cytomegalovirus Infections; Disease Progression; Female; Folic Acid; Heart Diseases; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Hyperplasia; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrahydrofolates; Time Factors; Ultrasonography; Vascular Diseases | 2005 |
Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease.
Topics: Aged; Analysis of Variance; Cognition; Double-Blind Method; Drug Synergism; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Male; Riboflavin; Treatment Outcome; Vascular Diseases; Vitamin B 12; Vitamin B 6; Vitamin B Complex; von Willebrand Factor | 2005 |
Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Topics: Aged; Cause of Death; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Pyridoxine; Renal Insufficiency, Chronic; Vascular Diseases; Vitamin B 12; Vitamin B Complex | 2007 |
Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocysteinaemia in vascular patients.
Topics: Amino Acid Metabolism, Inborn Errors; Folic Acid; Homocysteine; Humans; Middle Aged; Pyridoxine; Vascular Diseases | 1994 |
Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.
Topics: Adult; Age of Onset; Aged; Base Sequence; Blood Donors; Canada; DNA Primers; Gene Frequency; Genotype; Homocysteine; Homozygote; Humans; Infant, Newborn; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Reference Values; Regression Analysis; Vascular Diseases | 1996 |
Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.
Topics: Administration, Oral; Adult; Blood Flow Velocity; Brachial Artery; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Risk Factors; Vascular Diseases; Vasodilation | 1999 |
Plasmatic homocysteine response to vitamin supplementation in elderly people.
Topics: Aged; Aged, 80 and over; Dietary Supplements; Dose-Response Relationship, Drug; Female; Folic Acid; Homocysteine; Humans; Male; Statistics, Nonparametric; Vascular Diseases; Vitamins | 2000 |
153 other study(ies) available for homocysteine and Vascular Diseases
| Article | Year |
|---|---|
Hyperhomocysteinemia and Low Folate and Vitamin B12 Are Associated with Vascular Dysfunction and Impaired Nitric Oxide Sensitivity in Morbidly Obese Patients.
Topics: Adult; Alcohol Drinking; Arterioles; Bariatric Surgery; Brachial Artery; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nitric Oxide; Nutritional Status; Obesity, Morbid; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 2020 |
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases | 2020 |
MTR-G is a high-risk allele for lower-extremity arteriosclerotic occlusion.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Alleles; Case-Control Studies; Genotype; Homocysteine; Humans; Lower Extremity; Risk Factors; Vascular Diseases | 2022 |
Association of High Serum Homocysteine Levels and Severe Chronic Venous Disease.
Topics: Age Factors; Aged; Biomarkers; Chronic Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Sex Factors; Up-Regulation; Vascular Diseases; Veins | 2021 |
l-Homocysteine-induced cathepsin V mediates the vascular endothelial inflammation in hyperhomocysteinaemia.
Topics: Animals; Aorta, Thoracic; Cathepsins; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Hyperhomocysteinemia; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; THP-1 Cells; Vascular Diseases | 2018 |
Curcumin supplementation ameliorated vascular dysfunction and improved antioxidant status in rats fed a high-sucrose, high-fat diet.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; C-Reactive Protein; Cholesterol; Curcumin; Diet, High-Fat; Dietary Sucrose; Endothelium, Vascular; Homocysteine; Inflammation; Insulin; Insulin Resistance; Intercellular Adhesion Molecule-1; Liver; Male; Malondialdehyde; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Risk Factors; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2018 |
Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Brain Chemistry; Diet; Glucose; Homocysteine; Humans; Life Style; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; New York City; Positron-Emission Tomography; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
Elevated plasma homocysteine and cysteine are associated with endothelial dysfunction across menopausal stages in healthy women.
Topics: Adult; Aged; Brachial Artery; Cysteine; Diet; Endothelium, Vascular; Estradiol; Female; Homocysteine; Humans; Menopause; Middle Aged; Nutritional Status; Postmenopause; Vascular Diseases; Women's Health; Young Adult | 2019 |
The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome.
Topics: Adult; Brachial Artery; Carotid Intima-Media Thickness; Case-Control Studies; Copper; Endothelium, Vascular; Female; Homocysteine; Humans; Polycystic Ovary Syndrome; Regression Analysis; Thinness; Vascular Diseases; Vasodilation; Young Adult | 2013 |
Impaired renal function and biomarkers of vascular disease in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Biomarkers; Case-Control Studies; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Male; Mental Status Schedule; Multivariate Analysis; Risk Factors; Vascular Diseases | 2014 |
The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.
Topics: Adult; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multiple Sclerosis; Polymorphism, Genetic; Proteins; Retrospective Studies; Risk Factors; Risk Reduction Behavior; Vascular Diseases | 2014 |
Association of homocysteine level and vascular burden and cognitive function in middle-aged and older adults with chronic kidney disease.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Cognition; Cognition Disorders; Cognitive Dysfunction; Executive Function; Female; Homocysteine; Humans; Male; Middle Aged; Neuropsychological Tests; Renal Insufficiency, Chronic; Risk Factors; Vascular Diseases | 2016 |
Potential Risk Factors Associated With Vascular Diseases in Patients Receiving Treatment for Hypertension.
Topics: Adult; Aged; Antihypertensive Agents; DNA; Factor V; Female; Fibrin Fibrinogen Degradation Products; Genotype; Homocysteine; Humans; Hypertension; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Platelet Count; Polymorphism, Single Nucleotide; Prothrombin; Real-Time Polymerase Chain Reaction; Republic of Korea; Risk Factors; Vascular Diseases; Venous Thrombosis | 2016 |
Serum albumin and von Willebrand factor: possible markers for early detection of vascular damage in children undergoing peritoneal dialysis.
Topics: Adolescent; Apolipoproteins A; Apolipoproteins B; Blood Pressure; C-Reactive Protein; Carotid Intima-Media Thickness; Child; Cross-Sectional Studies; Female; Hemoglobins; Homocysteine; Humans; Kidney Failure, Chronic; Male; Parathyroid Hormone; Peritoneal Dialysis; Regression Analysis; Risk Factors; Serum Albumin; Vascular Diseases; von Willebrand Factor | 2016 |
Vascular biomarkers of cognitive performance in a community-based elderly population: the Dublin Healthy Ageing study.
Topics: Activities of Daily Living; Age Factors; Aged; Aged, 80 and over; Aging; Biomarkers; Cognition; Cross-Sectional Studies; Female; Homocysteine; Humans; Ireland; Life Style; Male; Memory; Mental Recall; Neuropsychological Tests; Population Surveillance; Up-Regulation; Vascular Diseases; Verbal Learning | 2008 |
Folate, homocysteine, and candidate genes for vascular disease in children with type 1 diabetes.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Ferredoxin-NADP Reductase; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Vascular Diseases | 2008 |
Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City.
Topics: Adolescent; Adult; Aged; Alleles; Argentina; Base Sequence; Cross-Sectional Studies; DNA Primers; Female; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Vascular Diseases; Young Adult | 2008 |
Plasma homocysteine levels and different forms of vascular disease in patients with dementia and other psychogeriatric diseases.
Topics: Aged; Aged, 80 and over; Aging; Creatinine; Dementia; Female; Homocysteine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Vascular Diseases | 2009 |
Methionine synthase reductase (MTRR) A66G polymorphism is not related to plasma homocysteine concentration and the risk for vascular disease.
Topics: Adult; Aged; Case-Control Studies; Female; Ferredoxin-NADP Reductase; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Vascular Diseases | 2009 |
Association between plasma homocysteine levels and mortality in elderly patients with mental illness.
Topics: Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; Folic Acid; Homocysteine; Humans; Kaplan-Meier Estimate; Kidney Function Tests; Male; Mental Disorders; Middle Aged; Proportional Hazards Models; Regression Analysis; Survival Analysis; Vascular Diseases; Vitamin B 12 | 2009 |
Homocysteine disulphides and vascular disease.
Topics: Cysteine; Disulfides; Homocysteine; Humans; Osmolar Concentration; Solubility; Vascular Diseases | 2009 |
Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness.
Topics: Aged; Aged, 80 and over; Alleles; Apolipoproteins E; Cohort Studies; Female; Homocysteine; Humans; Male; Mental Disorders; Middle Aged; Vascular Diseases | 2010 |
Association between homocysteine and endothelial dysfunction markers in stroke disease.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Creatinine; E-Selectin; Endothelium, Vascular; Female; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Stroke; Time Factors; Vascular Cell Adhesion Molecule-1; Vascular Diseases; Vitamin B Complex | 2010 |
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients.
Topics: Adult; Aging; Arginine; Carotid Arteries; Female; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Patient Selection; Prognosis; Severity of Illness Index; Vascular Diseases | 2010 |
Long-term cyclosporine treatment in non-transplanted rats and metabolic risk factors of vascular diseases.
Topics: Animals; Blood Coagulation; Body Weight; Cyclosporine; Fibrinogen; Glucose Tolerance Test; Homocysteine; Humans; Immunosuppressive Agents; Insulin; Leptin; Lipids; Male; Rats; Rats, Wistar; Risk Factors; Vascular Diseases | 2010 |
Plasma homocysteine--a marker of vascular disease in elderly patients with mental illness.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Female; Folic Acid; Homocysteine; Humans; Kidney; Logistic Models; Male; Mental Disorders; Middle Aged; Predictive Value of Tests; Vascular Diseases; Vitamin B 12 | 2010 |
Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over.
Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol; Chymotrypsin; Creatinine; Diet Surveys; Dietary Proteins; Energy Intake; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Male; Mortality; Nutritional Status; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; United Kingdom; Vascular Diseases; Vitamin B Complex | 2010 |
Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.
Topics: Acetylcholine; Animals; Antioxidants; Aorta; Astragalus propinquus; Cell Culture Techniques; Endothelial Cells; Endothelium, Vascular; Homocysteine; Humans; Nitric Oxide; Nitric Oxide Synthase; Phytotherapy; Plant Extracts; Rats; Reactive Oxygen Species; Saponins; Signal Transduction; Superoxide Dismutase; Triterpenes; Umbilical Veins; Vascular Diseases; Vasodilation | 2010 |
Extracellular heat shock protein 70 (HSPA1A) and classical vascular risk factors in a general population.
Topics: Adult; Antibodies; Atherosclerosis; C-Reactive Protein; Chaperonin 60; Cross-Sectional Studies; Female; Homocysteine; HSP70 Heat-Shock Proteins; Humans; Male; Middle Aged; Risk Factors; Vascular Diseases | 2010 |
Plasma homocysteine and cognition in elderly patients with dementia or other psychogeriatric diseases.
Topics: Aged; Aged, 80 and over; Cognition; Cognition Disorders; Creatinine; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Female; Folic Acid; Homocysteine; Humans; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Regression Analysis; Tomography, X-Ray Computed; Vascular Diseases; Vitamin B 12 | 2010 |
Letter to the editor: Is homocysteine the culprit molecule in vascular diseases or just a bystander?
Topics: Adipose Tissue; Animals; Cell Movement; Homocysteine; Humans; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; S-Adenosylhomocysteine; Vascular Diseases | 2010 |
Polyneuropathy and dementia in old age: common inflammatory and vascular parameters.
Topics: Aged; Aged, 80 and over; Aging; Cognition Disorders; Cohort Studies; Dementia; Female; Folic Acid; Geriatrics; Homocysteine; Humans; Inflammation; Male; Mental Status Schedule; Neopterin; Neural Conduction; Polyneuropathies; Sural Nerve; Vascular Diseases; Vitamin B 12 | 2011 |
The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.
Topics: Adult; Aged; C-Reactive Protein; China; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Vascular Diseases | 2011 |
Higher incidence of C677T polymorphism of the MTHFR gene in North Indian patients with vascular disease.
Topics: Adolescent; Adult; Aged; Biomarkers; Case-Control Studies; Chi-Square Distribution; Female; Gene Frequency; Genetic Predisposition to Disease; Heterozygote; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Immunoassay; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Phenotype; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Assessment; Risk Factors; Urban Population; Vascular Diseases; Young Adult | 2012 |
The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatments.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Betaine; Cholesterol; Cohort Studies; Female; Homocysteine; Hospitalization; Humans; Lipid Metabolism Disorders; Lipids; Male; Middle Aged; Models, Biological; Reproducibility of Results; Research Design; Vascular Diseases | 2012 |
Serum folate, total homocysteine levels and methylenetetrahydrofolate reductase 677C>T polymorphism in young healthy female Japanese.
Topics: Adolescent; Amplified Fragment Length Polymorphism Analysis; Child; Diet; Female; Folic Acid; Genetic Association Studies; Genetic Predisposition to Disease; Health Surveys; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Japan; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Vascular Diseases; Vitamin B 12; Vitamin B 6 | 2012 |
Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal.
Topics: Adult; Alcoholism; Arginine; Diagnostic and Statistical Manual of Mental Disorders; Germany; Homocysteine; Humans; Hyperhomocysteinemia; International Classification of Diseases; Male; Middle Aged; Nitric Oxide Synthase; Pilot Projects; Prospective Studies; Risk Factors; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors; Vascular Diseases | 2012 |
Elevated plasma homocysteine level is not primarily related to Alzheimer's disease.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Case-Control Studies; Cognitive Dysfunction; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Renal Insufficiency; Risk Factors; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 2012 |
Homocysteine in occlusive vascular disease: a risk marker or risk factor.
Topics: Adolescent; Adult; Aged; Biomarkers; Case-Control Studies; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Male; Middle Aged; Retrospective Studies; Risk Factors; Vascular Diseases; Vitamin B Complex; Young Adult | 2012 |
Folate supplementation after heart transplantation: effects on homocysteine plasma levels and allograft vascular disease.
Topics: Coronary Angiography; Creatinine; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Time Factors; Transplantation, Homologous; Vascular Diseases | 2002 |
Folic acid and the elderly.
Topics: Aged; Anemia; Dietary Supplements; Folic Acid; Homocysteine; Humans; Microcirculation; Risk Factors; Vascular Diseases | 2002 |
Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients.
Topics: Female; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Transcobalamins; Vascular Diseases; Vitamin B 12 | 2002 |
Homocysteine and vascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Folic Acid; Hematinics; Homocysteine; Humans; Pyridines; Thiazepines; Vascular Diseases | 2002 |
Plasma homocysteine and malondialdehyde are correlated in an age- and gender-specific manner.
Topics: Adult; Age Factors; Aged; Aging; Biomarkers; Female; Homocysteine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reference Values; Risk Factors; Sex Characteristics; Sex Factors; Vascular Diseases | 2002 |
Homocysteine, vitamin B6, and vascular disease in patients with AD.
Topics: Aged; Alzheimer Disease; Female; Homocysteine; Humans; Male; Vascular Diseases; Vitamin B 6 | 2002 |
Cystathionine beta-synthase polymorphisms and hyperhomocysteinaemia: an association study.
Topics: Adult; Cystathionine beta-Synthase; Fasting; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Vascular Diseases | 2003 |
Endothelial markers and homocysteine in patients with classic Fabry disease.
Topics: Adolescent; Adult; Cohort Studies; Creatinine; E-Selectin; Endothelin-1; Fabry Disease; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; P-Selectin; Thrombomodulin; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2002 |
Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.
Topics: Creatinine; Female; Hemoglobins; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Risk Factors; Vascular Diseases | 2003 |
Hyperhomocysteinemia and oxidative stress during dialysis treatment.
Topics: Adult; Aged; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Risk Factors; Vascular Diseases | 2003 |
Homocysteine and the brain: vascular risk factor or neurotoxin?
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Clinical Trials as Topic; Dementia, Vascular; Homocysteine; Humans; Neurotoxins; Risk Factors; Vascular Diseases | 2003 |
Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular dis
Topics: Aged; Aged, 80 and over; Aging; Arteriosclerosis; Biomarkers; Case-Control Studies; Cohort Studies; Dementia; Female; Geriatric Assessment; Homes for the Aged; Homocysteine; Humans; Male; Middle Aged; Nursing Homes; Probability; Prognosis; Reference Values; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Vascular Diseases | 2003 |
Relation of homocysteine and C-reactive protein to urinary albumin loss.
Topics: Adult; Aged; Albuminuria; C-Reactive Protein; Creatinine; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Vascular Diseases | 2004 |
Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Cyclic GMP; Diastole; Endothelium, Vascular; Female; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitrites; Regional Blood Flow; Renal Circulation; Renal Dialysis; Risk Factors; Statistics as Topic; Systole; Time Factors; Treatment Outcome; Vascular Diseases; Vasodilation | 2004 |
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study.
Topics: Aged; Black People; Cohort Studies; Female; Hispanic or Latino; Homocysteine; Humans; Male; Methylmalonic Acid; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Vascular Diseases; White People | 2004 |
Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betaine; Carnitine; Creatinine; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Sarcosine; Sex Characteristics; Vascular Diseases | 2005 |
Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.
Topics: Animals; Antioxidants; Arteries; Coronary Vessels; Curcumin; Endothelium, Vascular; Homocysteine; In Vitro Techniques; Models, Animal; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Superoxides; Swine; Vascular Diseases; Vasodilation | 2004 |
Hyperhomocysteinemia: cause or effect of disease?
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Risk Factors; Vascular Diseases | 2005 |
Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
Topics: Adult; Aged; Albuminuria; Antioxidants; Diabetes Mellitus, Type 2; Female; Glutathione; Glutathione Peroxidase; Homocysteine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Vascular Diseases | 2005 |
Plasma homocysteine concentration and its relation to symptoms of vascular disease in psychogeriatric patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Creatinine; Cystatin C; Cystatins; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Protein S; Vascular Diseases; Vitamin B 12 | 2005 |
Hyperhomocysteinaemia and aortic calcification are associated with fractures in patients on haemodialysis.
Topics: Aged; Calcinosis; Cross-Sectional Studies; Female; Fractures, Bone; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spinal Fractures; Vascular Diseases | 2005 |
Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression.
Topics: Adult; Biomarkers; Cells, Cultured; Cycloheximide; Cytokines; Dactinomycin; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Expression Regulation; Homocysteine; Humans; Macrophage Migration-Inhibitory Factors; Male; Monocytes; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Vascular Diseases | 2005 |
Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease.
Topics: Aged; Chromatography, High Pressure Liquid; Fasting; Female; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Male; Methionine; Middle Aged; Regression Analysis; Vascular Diseases | 2005 |
Homocysteine trials--clear outcomes for complex reasons.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methylation; Myocardial Infarction; Secondary Prevention; Vascular Diseases; Vitamin B 12; Vitamin B 6 | 2006 |
Homocysteine level and cognitive function in patients with arterial disease: the second manifestations of ARTerial Disease Study.
Topics: Adult; Aged; Cognition; Cognition Disorders; Cross-Sectional Studies; Female; Homocysteine; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Risk Factors; Vascular Diseases | 2006 |
[Hyperhomocysteinemia as a risk factor for vascular diseases].
Topics: Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Risk Factors; Vascular Diseases | 2006 |
[Homocysteine lowering with folic acid and B vitamins in vascular disease].
Topics: Aged; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Vascular Diseases; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2006 |
A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice.
Topics: Chromatography, High Pressure Liquid; Homocysteine; Humans; Mass Spectrometry; Reference Standards; Vascular Diseases | 2006 |
Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Depressive Disorder; Female; Folic Acid; Hematocrit; Homocysteine; Humans; Male; Mental Disorders; Middle Aged; Nutritional Status; Population; Sweden; Vascular Diseases; Vitamin B 12 | 2006 |
Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly.
Topics: Aged; Aging; Alleles; Apolipoprotein E4; C-Reactive Protein; Cohort Studies; Confidence Intervals; Dementia; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Lipoproteins, VLDL; Male; Odds Ratio; Prospective Studies; Risk Factors; Vascular Diseases | 2006 |
Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation.
Topics: Chromatography, High Pressure Liquid; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Liver Transplantation; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Retrospective Studies; Risk Factors; Vascular Diseases | 2008 |
Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease.
Topics: Aged; Aged, 80 and over; Aging; Brain; Cognition Disorders; Female; Homocysteine; Humans; Male; Memory Disorders; Middle Aged; Reference Values; Vascular Diseases | 2007 |
Large-conductance Ca2+-activated K+ currents blocked and impaired by homocysteine in human and rat mesenteric artery smooth muscle cells.
Topics: Animals; Calcium; Dose-Response Relationship, Drug; Homocysteine; Humans; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium Channel Blockers; Rats; Rats, Wistar; Vascular Diseases | 2007 |
Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis.
Topics: Aged; Aged, 80 and over; Aging; Creatinine; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Kidney Function Tests; Male; Mental Disorders; Psychiatric Status Rating Scales; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 2007 |
B vitamins for the prevention of vascular disease: insufficient evidence to justify treatment.
Topics: Homocysteine; Humans; Renal Insufficiency, Chronic; Vascular Diseases; Vitamin B Complex | 2007 |
Homocysteine, migration and early vascular impairment in people of African descent.
Topics: Adult; Biomarkers; Black People; Cross-Sectional Studies; Emigration and Immigration; Female; Folic Acid; Homocysteine; Humans; Jamaica; Male; Middle Aged; Plethysmography; Risk Factors; Statistics, Nonparametric; United Kingdom; Vascular Diseases | 2008 |
Inhibitory effect of Ginkgo biloba extract on hyperhomocysteinemia-induced intimal thickening in rabbit abdominal aorta after balloon injury.
Topics: Animals; Aorta, Abdominal; Blotting, Western; Catheterization; Cyclin-Dependent Kinase Inhibitor p21; Ginkgo biloba; Homocysteine; Hyperhomocysteinemia; Male; Matrix Metalloproteinase 9; Plant Extracts; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tunica Intima; Vascular Diseases | 2008 |
Homocysteine, vitamins, and vascular disease prevention: more negative results.
Topics: Evidence-Based Medicine; Folic Acid; Food, Fortified; Homocysteine; Humans; Meta-Analysis as Topic; Primary Prevention; Randomized Controlled Trials as Topic; Risk Factors; Vascular Diseases; Vitamins | 2008 |
Plasma S-adenosylhomocysteine versus homocysteine as a marker for vascular disease.
Topics: Animals; Biomarkers; Homocysteine; Mice; S-Adenosylhomocysteine; Vascular Diseases | 2008 |
1H NMR determination of urinary betaine in patients with premature vascular disease and mild homocysteinemia.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Betaine; Creatinine; Glycine; Homocysteine; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Regression Analysis; Sarcosine; Vascular Diseases | 1995 |
Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Regression Analysis; Renal Dialysis; Risk Factors; Uremia; Vascular Diseases | 1995 |
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.
Topics: Adult; Base Sequence; DNA, Complementary; Enzyme Stability; Escherichia coli; Female; Homocysteine; Humans; Kidney; Liver; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Quebec; Risk Factors; Temperature; Vascular Diseases | 1995 |
Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Amino Acid Metabolism, Inborn Errors; Cells, Cultured; Cystathionine beta-Synthase; Female; Fibroblasts; Homocysteine; Hot Temperature; Humans; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Protein Denaturation; Risk Factors; Vascular Diseases | 1995 |
Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations.
Topics: Animals; Blood Vessels; Captopril; Caseins; Diet; Drug Combinations; Hemorheology; Hindlimb; Homocysteine; Hydrochlorothiazide; Hypertension; Male; Methionine; Swine; Swine, Miniature; Vascular Diseases | 1995 |
Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular disease.
Topics: Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vascular Diseases | 1993 |
Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.
Topics: Base Sequence; Cells, Cultured; Endothelium, Vascular; Homocysteine; Humans; Molecular Sequence Data; Risk Factors; RNA, Messenger; Thromboplastin; Thrombosis; Vascular Diseases | 1993 |
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
Topics: Animals; Carotid Arteries; Choline Deficiency; Cross-Over Studies; Diet; Extremities; Folic Acid Deficiency; Homocysteine; Homocystine; Macaca fascicularis; Methionine; Protein C; Random Allocation; Regional Blood Flow; Thrombomodulin; Vascular Diseases; Vascular Resistance; Vasomotor System | 1996 |
Hyperhomocysteinaemia--a common finding in a psychogeriatric population.
Topics: Aged; Aged, 80 and over; Dementia; Female; Folic Acid; Homocysteine; Humans; Male; Vascular Diseases; Vitamin B 12 | 1996 |
The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Neural Tube Defects; Oxidoreductases; Phenotype; Risk Factors; Vascular Diseases; Vitamin B 12 | 1996 |
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
Topics: Adult; Arteriosclerosis; Blood Chemical Analysis; Case-Control Studies; Fasting; Female; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Logistic Models; Male; Methionine; Middle Aged; Risk Factors; Smoking; Vascular Diseases | 1997 |
[Deregulation of homocysteine metabolism and consequences for the vascular system].
Topics: Folic Acid; Homocysteine; Humans; Pyridoxine; Vascular Diseases; Vitamin B 12 Deficiency | 1997 |
Elevated homocyst(e)ine levels with preeclampsia.
Topics: Adult; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Parity; Pre-Eclampsia; Pregnancy; Risk Factors; Vascular Diseases; Vitamin B 12 | 1997 |
Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over.
Topics: Aged; alpha 1-Antichymotrypsin; Calcium; Creatinine; England; Female; Folic Acid; Homocysteine; Humans; Lutein; Male; Nutritional Status; Random Allocation; Reference Values; Regression Analysis; Risk Factors; Urea; Vascular Diseases; Vitamin B 12; Zinc | 1997 |
Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Endothelium, Vascular; Female; Homocysteine; Homocystine; Humans; Male; Middle Aged; Multivariate Analysis; Risk Factors; Vascular Diseases; Vasodilation | 1997 |
High prevalence of hyperhomocysteinemia and asymptomatic vascular disease in siblings of young patients with vascular disease and hyperhomocysteinemia.
Topics: Adult; Blood Pressure; Carotid Stenosis; Diabetes Mellitus; Disease Susceptibility; Echocardiography; Exercise Test; Fasting; Female; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Male; Mass Screening; Methionine; Middle Aged; Multivariate Analysis; Nuclear Family; Prevalence; Risk Factors; Single-Blind Method; Smoking; Vascular Diseases | 1997 |
Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
Topics: Adult; Analysis of Variance; Arteriosclerosis; Avitaminosis; Case-Control Studies; Cerebrovascular Disorders; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Pyridoxine; Risk Factors; Vascular Diseases; Vitamins | 1998 |
Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein.
Topics: Antibody Specificity; Apolipoprotein B-100; Apolipoproteins B; Binding, Competitive; Cystamine; Enzyme-Linked Immunosorbent Assay; Homocysteine; Lipoproteins, LDL; Lysine; Vascular Diseases | 1998 |
[Homocysteinemia as a risk factor for vascular disease-which patients should be treated?].
Topics: Homocysteine; Humans; Methionine; Middle Aged; Odds Ratio; Risk Factors; Vascular Diseases | 1998 |
Homocysteine and vascular disease.
Topics: Dietary Supplements; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors; Vascular Diseases; Vitamin B 12 | 1998 |
Homocysteine and vascular disease: emerging connections.
Topics: Homocysteine; Humans; Risk Assessment; Vascular Diseases | 1998 |
Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease.
Topics: Adult; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Regression Analysis; Risk Factors; Uric Acid; Vascular Diseases | 1998 |
Hyperhomocysteinaemia.
Topics: Aortic Aneurysm, Abdominal; Homocysteine; Humans; Vascular Diseases | 1998 |
Measurement and use of total plasma homocysteine. American Society of Human Genetics/American College of Medical Genetics Test and Transfer Committee Working Group.
Topics: Blood Proteins; Blood Specimen Collection; Homocysteine; Humans; Laboratories; Quality Control; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; United States; Vascular Diseases | 1998 |
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Case-Control Studies; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Memory Disorders; Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors; Vascular Diseases; Vitamin B 12 | 1998 |
Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adolescent; Adult; Aged; Aged, 80 and over; Erythrocytes; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Polymorphism, Genetic; Risk Factors; Vascular Diseases; Vitamin B 12 | 1998 |
Nutritional hyperhomocysteinaemia.
Topics: Diet; Homocysteine; Humans; Methionine; Vascular Diseases | 1999 |
Plasma homocysteine levels increase in women during psychological stress.
Topics: Adult; Blood Pressure; Female; Follicle Stimulating Hormone; Heart Rate; Homocysteine; Humans; Luteinizing Hormone; Menopause; Menstrual Cycle; Middle Aged; Risk Factors; Stress, Psychological; Vascular Diseases | 1999 |
Nigral endothelial dysfunction, homocysteine, and Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carboxy-Lyases; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Vascular Diseases | 1999 |
Homocysteine, vitamins and sex.
Topics: Folic Acid; Homocysteine; Humans; Pyridoxine; Sex Factors; Vascular Diseases; Vitamin B 12 | 1999 |
Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
Topics: Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Male; Menopause; Pyridoxine; Risk Factors; Sex Factors; Vascular Diseases; Vitamin B 12 | 1999 |
Within-person variation of plasma homocysteine and effects of posture and tourniquet application.
Topics: Adult; Blood Specimen Collection; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Posture; Risk Factors; Vascular Diseases | 1999 |
Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries.
Topics: Adult; Brachial Artery; Carotid Artery, Common; Endothelium, Vascular; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Regional Blood Flow; Regression Analysis; Vascular Diseases; Vasodilation | 1999 |
Homocysteine and fibrinolysis in acute occlusive coronary events.
Topics: Homocysteine; Humans; Vascular Diseases | 1999 |
Key references: Homocysteine and atherothrombotic vascular disease.
Topics: Arteriosclerosis; Biomarkers; Embolism, Cholesterol; Homocysteine; Humans; Hyperhomocysteinemia; Vascular Diseases | 2000 |
Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction.
Topics: Adult; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Pyridoxine; Risk Factors; Thrombomodulin; Vascular Diseases; von Willebrand Factor | 1999 |
A theory for the mechanism of homocysteine-induced vascular pathogenesis.
Topics: Amino Acids; Calcium; Chelating Agents; Cholesterol; Endothelium, Vascular; Homocysteine; Humans; Models, Biological; Thrombosis; Vascular Diseases | 1999 |
Homocysteine levels in healthy New Zealanders and those with vascular disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Homocysteine; Humans; Lipids; Lipoproteins; Male; Middle Aged; New Zealand; Reference Values; Vascular Diseases | 1999 |
Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
Topics: Aged; Arteries; Chromatography, High Pressure Liquid; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Risk Factors; Vascular Diseases | 2000 |
The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Cohort Studies; Deficiency Diseases; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Renal Dialysis; Risk Factors; Vascular Diseases | 2000 |
Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
Topics: Adult; Aged; Animals; Case-Control Studies; Chromatography, High Pressure Liquid; Erythrocytes; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Time Factors; Tissue Distribution; Vascular Diseases | 2000 |
[Homocysteinemia: role in vascular disease].
Topics: Cerebral Infarction; Coronary Disease; Homocysteine; Humans; Risk Factors; Vascular Diseases | 2000 |
A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; DNA Mutational Analysis; Female; Folic Acid; Genotype; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Oxidoreductases; Placenta; Pregnancy; Vascular Diseases | 2000 |
Tissue factor pathway inhibitor levels in patients with homocystinuria.
Topics: Adult; Betaine; Biomarkers; Cystathionine beta-Synthase; Endothelium; Factor VII; Female; Fibrinolytic Agents; Heparin; Homocysteine; Homocystinuria; Homozygote; Humans; Lipoproteins; Male; Protein C; Pyridoxine; Serine Proteinase Inhibitors; Thrombomodulin; Thromboplastin; Vascular Diseases; Vitamin B 12 | 2000 |
Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia.
Topics: Adult; Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Homocysteine; Humans; Hyperhomocysteinemia; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Ultrasonography, Prenatal; Vascular Diseases | 2000 |
Homocysteine: more questions than answers.
Topics: Dietary Supplements; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vascular Diseases; Vitamins | 2000 |
Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease.
Topics: Adolescent; Adult; Aged; Antioxidants; Child; Cysteine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Risk Factors; Vascular Diseases | 2001 |
Homocysteine and B vitamins in dementia.
Topics: Aged; Dementia; Homocysteine; Humans; Risk Factors; Vascular Diseases; Vitamin B Complex | 2001 |
Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore.
Topics: Aged; Aging; Asian People; Cohort Studies; Exercise; Female; Folic Acid; Genotype; Homocysteine; Humans; Interviews as Topic; Life Style; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies; Pyridoxine; Risk Factors; Sex Factors; Singapore; Smoking; Vascular Diseases; Vitamin B 12 | 2001 |
Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alcohol Drinking; Coffee; Cross-Sectional Studies; Dietary Supplements; Dose-Response Relationship, Drug; Female; Folic Acid; Homocysteine; Humans; Life Style; Linear Models; Male; Methylmalonic Acid; Risk Factors; Smoking; Tea; Vascular Diseases; Vitamin B 12 | 2001 |
Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease.
Topics: Aged; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Vascular Diseases | 2001 |
Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project.
Topics: Adult; Case-Control Studies; Creatinine; Cysteine; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Pyridoxine; Risk Factors; Vascular Diseases; Vitamin B 12 | 2001 |
Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease.
Topics: Aorta, Thoracic; Blotting, Northern; Cells, Cultured; Chemokine CCL2; Chemotaxis; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Homocysteine; Humans; Interleukin-8; RNA, Messenger; Sulfur Compounds; Time Factors; U937 Cells; Vascular Diseases | 2001 |
[Can blood homocysteine explain the family history of vascular diseases?].
Topics: Adult; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vascular Diseases | 2001 |
Mild hyperhomocysteinemia: vitamin supplementation or not?
Topics: Adult; Case-Control Studies; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Mutation; Polymorphism, Genetic; Vascular Diseases; Vitamins | 2001 |
Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?
Topics: Dementia, Vascular; Diet; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Models, Chemical; Neopterin; Oxidative Stress; Oxygen; Vascular Diseases; Vitamin B 12 | 2001 |
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
Topics: Aged; Aged, 80 and over; Aging; Dementia; Diabetes Complications; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammatory Bowel Diseases; Kinetics; Linear Models; Male; Methionine; Nutrition Disorders; Odds Ratio; Renal Insufficiency; Vascular Diseases | 2001 |
Total serum homocysteine--a predictor of extracranial carotid artery stenosis in male patients with symptomatic peripheral arterial disease.
Topics: Aged; Arteries; Carotid Artery, Internal; Carotid Stenosis; Forecasting; Homocysteine; Humans; Male; Middle Aged; Ultrasonography; Vascular Diseases | 2001 |
Homocystine solubility and vascular disease.
Topics: Homocysteine; Homocystine; Humans; Kinetics; Oxidation-Reduction; Risk Factors; Solubility; Vascular Diseases | 2002 |
Total homocysteine as a risk factor for vascular disease in renal transplant recipients.
Topics: Adult; Biomarkers; Blood Pressure; Body Mass Index; Creatinine; Female; Homocysteine; Humans; Kidney Transplantation; Male; Proteinuria; Risk Factors; Smoking; Time Factors; Vascular Diseases | 2002 |
Homocysteine, vitamin B6, and vascular disease in AD patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angina Pectoris; Brain Infarction; Coronary Disease; Female; Heart Failure; Homocysteine; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Odds Ratio; Pyridoxal Phosphate; Stroke; Vascular Diseases; Vitamin B 6 | 2002 |
Erythrocyte mean cellular volume and its relation to serum homocysteine, vitamin B12 and folate.
Topics: Cerebrovascular Disorders; Erythrocyte Volume; Female; Folic Acid; Hemodynamics; Hemoglobins; Homocysteine; Humans; Male; Middle Aged; Vascular Diseases; Vitamin B 12 | 2002 |
Relation between plasma homocysteine and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Homocysteine; Humans; Male; Matched-Pair Analysis; Vascular Diseases | 2002 |
Hyperhomocyst(e)inemia induces accelerated transplant vascular sclerosis in syngeneic and allogeneic rat cardiac transplants.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Creatinine; Cystine; Graft Rejection; Graft Survival; Heart Transplantation; Homocysteine; Hyperhomocysteinemia; Male; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sclerosis; Time Factors; Transplantation, Heterotopic; Transplantation, Homologous; Transplantation, Isogeneic; Vascular Diseases | 2002 |
Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people.
Topics: Adult; Age Factors; Aged; Cognition Disorders; Cross-Sectional Studies; Dementia; Depressive Disorder; Female; Homocysteine; Humans; Male; Vascular Diseases | 1992 |
Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status.
Topics: Adult; Aged; Aging; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Menopause; Methionine; Middle Aged; Pyridoxal Phosphate; Sex Characteristics; Vascular Diseases; Vitamin B 12 | 1992 |
[The homocysteinemia vascular risk factor. Methodologies and application to a clinical case].
Topics: Amino Acids; Arterial Occlusive Diseases; Chromatography; Homocysteine; Humans; Male; Methionine; Middle Aged; Molecular Structure; Risk Factors; Vascular Diseases | 1991 |
Homocysteinemia: a risk factor for vascular disease.
Topics: Cystathionine beta-Synthase; Heterozygote; Homocysteine; Humans; Risk; Vascular Diseases | 1991 |
Hyperhomocysteinemia: an independent risk factor for vascular disease.
Topics: Cerebrovascular Disorders; Coronary Disease; Cystathionine beta-Synthase; Female; Heterozygote; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors; Vascular Diseases | 1991 |
Endothelium in the pathogenesis of main vascular diseases.
Topics: Animals; Arteriosclerosis; Aspirin; Cholic Acid; Cholic Acids; Endothelium, Vascular; Heparin; Homocysteine; Rats; Stress, Psychological; Thrombosis; Vascular Diseases | 1989 |
Premature vascular disease in homocysteinaemia. Symposium held during the 10th International Congress on Thrombosis. Athens, May 22-27, 1988. Proceedings.
Topics: Child; Homocysteine; Humans; Vascular Diseases | 1989 |
Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease.
Topics: Adolescent; Adult; Fasting; Female; Homocysteine; Humans; Male; Menopause; Methionine; Middle Aged; Sulfhydryl Compounds; Vascular Diseases | 1988 |
Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency.
Topics: Cystathionine beta-Synthase; Heterozygote; Homocysteine; Homocystinuria; Humans; Hydro-Lyases; Vascular Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 1988 |
Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease.
Topics: Adult; Creatinine; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Vascular Diseases | 1988 |
Vascular disease and homocysteine metabolism.
Topics: Adult; Cystathionine beta-Synthase; Heterozygote; Homocysteine; Humans; Middle Aged; Vascular Diseases | 1985 |